Avicanna To Hold Full Year 2024 Earnings Conference Call

TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, invites interested parties to participate in a conference call with Aras Azadian, Chief Executive Officer, and also Phil Cardella, Chief Financial Officer, where Mr. Azadian and Mr. Cardella will discuss the Company’s Full Year 2024 financial results.

Read more at globenewswire.com